Further analysis of tumor immunologic characteristics and the correlation of ferroptosis with UVM revealed that TRPM4 and TRPV2 are considered as two novel prognostic biomarkers and promising targeted therapy in UVM. Here, TRPM4 is linked to neoplasm.